Sarah Ashby - Psychemedics VP Counsel
Insider
Sarah Ashby is VP Counsel of Psychemedics
| Phone | 800 527 7424 |
| Web | https://www.psychemedics.com |
Psychemedics Management Efficiency
The company has Return on Asset of (0.1624) % which means that on every $100 spent on assets, it lost $0.1624. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.6133) %, meaning that it generated no profit with money invested by stockholders. Psychemedics' management efficiency ratios could be used to measure how well Psychemedics manages its routine affairs as well as how well it operates its assets and liabilities.Psychemedics has 2.3 M in debt with debt to equity (D/E) ratio of 0.36, which is OK given its current industry classification. Psychemedics has a current ratio of 2.02, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Psychemedics until it has trouble settling it off, either with new capital or with free cash flow. So, Psychemedics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Psychemedics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Psychemedics to invest in growth at high rates of return. When we think about Psychemedics' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Ryan Douglas | Exagen Inc | N/A | |
| Andrew Macan | Neuronetics | 51 | |
| Camilla Zuckero | Castle Biosciences | N/A | |
| Jinxiang Li | Burning Rock Biotech | 39 | |
| John Boniface | Sera Prognostics | 63 | |
| Zvi David | DarioHealth Corp | 63 | |
| Michael Petras | Sotera Health Co | 56 | |
| Paul Kearney | Sera Prognostics | 57 | |
| RN RN | Castle Biosciences | 56 | |
| Sally Turner | Sotera Health Co | N/A | |
| Debra Zack | Exagen Inc | 65 | |
| MD FACR | Exagen Inc | N/A | |
| Nadia Altomare | Sera Prognostics | 53 | |
| Robert Harrison | Sera Prognostics | 59 | |
| Michael Biehl | Sotera Health Co | 68 | |
| Kara Thornton | Neuronetics | N/A | |
| Stephen MS | Neuronetics | 61 | |
| Kristin Gibbs | Sotera Health Co | N/A | |
| Steven Graves | Sera Prognostics | N/A | |
| John Abbott | Castle Biosciences | N/A | |
| Yusheng Han | Burning Rock Biotech | 46 | |
Management Performance
| Return On Equity | -0.61 | |||
| Return On Asset | -0.16 |
Psychemedics Leadership Team
Elected by the shareholders, the Psychemedics' board of directors comprises two types of representatives: Psychemedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Psychemedics. The board's role is to monitor Psychemedics' management team and ensure that shareholders' interests are well served. Psychemedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Psychemedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Weisenhoff, Principal Manager | ||
| Raymond Kubacki, Chairman, CEO and Pres | ||
| Charles IV, Ex VP | ||
| Shannon Shoemaker, Chief Officer | ||
| Michael Schaffer, VP of Laboratory Operations | ||
| Werner Baumgartner, Founder | ||
| Annette Baumgartner, Founder | ||
| Sarah Ashby, VP Counsel | ||
| Patrick Kinney, Secretary | ||
| Brian Hullinger, CEO President | ||
| Daniella Mehalik, Vice Finance |
Psychemedics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Psychemedics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.61 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | (0.22) % | |||
| Operating Margin | (0.19) % | |||
| Current Valuation | 14.22 M | |||
| Shares Outstanding | 5.89 M | |||
| Shares Owned By Insiders | 23.14 % | |||
| Shares Owned By Institutions | 20.22 % | |||
| Number Of Shares Shorted | 38.6 K | |||
| Price To Earning | 92.08 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Psychemedics Pink Sheet
If you are still planning to invest in Psychemedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Psychemedics' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |